CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
LIGHTHEART aims to develop an innovative surgical bioprinting tool that combines bioprinting and optogenetics to create engineered cardiac muscle directly at the site of heart injury. This approach seeks to improve treatment options for patients with advanced heart disease by enabling the fabrication of tissues that mi…
Heart failure remains a leading cause of mortality worldwide taking an estimate of 16 million lives each year.
Cardiac tissue engineering solutions that can improve the quality of life of those with advanced heart disease have proved challenging so far.
Bioprinting is an exciting technology that holds promise to fabricate tissues and organs.
Lab-grown engineered cardiac muscle requires at least four weeks to maturate in a bioreactor.
In LIGHTHEART, an off-the-shelf solution will be developed for…
RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
